Fibrinolytics in reduction of risk of thromboembolism
Fibrinolytic activity in both the blood and vein wall has been shown to be impaired in patients with acute DVT's. This may enhance the formation of thrombi.
Unfortunately, drugs which enhance fibrinolytic activity, e.g. phenformin and ethyloestrenol, have not been shown to be effective at preventing DVT.
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page